T. Shiratori

The efficacy of nintedanib in 158 patients with idiopathic pulmonary fibrosis in real-world settings: A multicenter retrospective study

S. Tasaka, S. Takanashi, Y. Hasegawa, 2021, SAGE open medicine.

Efficacy of pembrolizumab for patients with both high PD‐L1 expression and an MET exon 14 skipping mutation: A case report

S. Tasaka, Hisashi Tanaka, K. Taima, 2019, Thoracic cancer.

A Case of Large Cell Neuroendocrine Carcinoma Successfully Treated with Nivolumab

S. Tasaka, Hisashi Tanaka, K. Taima, 2019, Haigan.

Interferon-stimulated gene 60 (ISG60) constitutes a negative feedback loop in the downstream of TLR3 signaling in hCMEC/D3 cells

T. Matsumiya, T. Imaizumi, H. Yoshida, 2018, Journal of Neuroimmunology.

Toll-like receptor 3 signaling induces interferon-induced transmembrane protein 1 in BEAS-2B cells

S. Tasaka, T. Imaizumi, S. Kawaguchi, 2022, Experimental biology and medicine.

Effect of nintedanib on non‐small cell lung cancer in a patient with idiopathic pulmonary fibrosis: A case report and literature review

S. Tasaka, S. Takanashi, Hisashi Tanaka, 2020, Thoracic cancer.

Induction of C‐C motif chemokine ligand 2 through Toll‐like receptor 3 signaling in human cerebral microvascular endothelial cell/D3 cells: possible regulation by nuclear factor‐κB

T. Matsumiya, T. Imaizumi, H. Yoshida, 2019, Clinical and Experimental Neuroimmunology.